Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMIST: TST vs TST + QFT-IT for TB Contact Tracing
NCT01223534Phase 4Completed
- Sponsor
- Bellvitge University Hospital
- Start
- Jul 2010
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of isoniazid in Tuberculosis (TB), sponsored by Bellvitge University Hospital. Started Jul 2010; status: completed.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01223534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01223534.